The medicines decisions made at the NENC Clinical Effectiveness and Governance (CEG) Subcommittee December 2025 meeting can now be found at: https://ntag.nhs.uk/meetings/decision-summaries/

This includes the recommendations made by NTAG at its November 2025 meeting and NICE Technology appraisals from the 1st August 2025 to 30th September 2025.

The following new guidelines were approved and can be found at:

The following reviewed guidelines were approved and can be found at:

The following reviewed shared care guidelines were approved and can be found at: https://ntag.nhs.uk/shared-care-guidelines/

  • NENC Shared Care Protocol – Sativex for the treatment of spasticity in multiple sclerosis – minor updates to match latest SPC and review date extended for a further 2 years

The following shared care guidelines have had their review date extended until March 2026 and are available at: https://ntag.nhs.uk/shared-care-guidelines/

  • NENC Shared Care Protocol – Riluzole for patients in adult services